Gail McIntyre
Director/Board Member bei ARAVIVE, INC.
Vermögen: 8 121 $ am 31.12.2023
Profil
Gail Frances McIntyre is currently working as the Secretary & Director at Aravive, Inc. She is also a Member at the American College of Toxicology and the Drug Information Association.
Previously, she held positions as a Director at TAXIS Pharmaceuticals, Inc. and Neoantigenics, Inc. She was also the Head-Compound Partnering Business at Pharmaceutical Product Development LLC.
From 2010 to 2014, she served as the Senior Vice President-Research at Furiex Pharmaceuticals, Inc. She has also been a Member of the American Association for the Advancement of Science and The American Society for Clinical Pathology.
In 2017 and 2018, she was the Senior Vice President-Research & Development at Aravive Biologics, Inc. She was the Vice President-Development at Meryx, Inc. from 2014 to 2016.
Additionally, she worked as a Principal at Intellidev Consulting LLC from 2014 to 2016.
Dr. McIntyre completed her undergraduate degree at Merrimack College and holds graduate and doctorate degrees from The University of North Carolina at Chapel Hill.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ARAVIVE, INC.
0,09% | 03.08.2023 | 65 490 ( 0,09% ) | 8 121 $ | 31.12.2023 |
Aktive Positionen von Gail McIntyre
Unternehmen | Position | Beginn |
---|---|---|
ARAVIVE, INC. | Director/Board Member | 08.04.2020 |
American College of Toxicology | Corporate Officer/Principal | 02.06.2010 |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Corporate Officer/Principal | 02.06.2010 |
Ehemalige bekannte Positionen von Gail McIntyre
Unternehmen | Position | Ende |
---|---|---|
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Chief Tech/Sci/R&D Officer | 01.10.2018 |
Intellidev Consulting LLC | Corporate Officer/Principal | 01.01.2016 |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Corporate Officer/Principal | 01.01.2016 |
FURIEX PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01.12.2014 |
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Corporate Officer/Principal | - |
Ausbildung von Gail McIntyre
Merrimack College | Undergraduate Degree |
The University of North Carolina at Chapel Hill | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARAVIVE, INC. | Health Technology |
Private Unternehmen | 11 |
---|---|
Pharmaceutical Product Development LLC
Pharmaceutical Product Development LLC Miscellaneous Commercial ServicesCommercial Services Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
Furiex Pharmaceuticals, Inc.
Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Furiex Pharmaceuticals, Inc. operates as a drug development collaboration company that uses innovative clinical development design to accelerate and increase value of drug development programs by advancing them through the drug discovery and development process in a cost-efficient manner. Its drug development programs are designed and driven by a core team with extensive drug development experience. Furiex Pharmaceuticals was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
TAXIS Pharmaceuticals, Inc.
TAXIS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology TAXIS Pharmaceuticals, Inc develops antibiotics for the treatment of multidrug-resistant bacteria. The company was founded by Edmond J. LaVoie, Gregory G. Mario and Daniel S. Pilch in 2009 and is headquartered in Monmouth Junction, NJ. | Health Technology |
Neoantigenics, Inc.
Neoantigenics, Inc. Medical SpecialtiesHealth Technology Neoantigenics, Inc. developes therapeutic plus diagnostic products. The firm focuses on developing oncology theranostics products, founded on the novel science around oocyte (egg)-associated cancer proteins. The company was founded Brian A. Pollok, John C. Herr and Edward J. Leary in July 2012 and is headquartered in Charlottesville, VA. | Health Technology |
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
American College of Toxicology | |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services The Drug Information Association is a non-profit multidisciplinary association that operates to promote health and well-being. The non-profit company is based in Horsham, PA. Marwan Fathallah has been the CEO of the company since 2023. | Commercial Services |
The American Society for Clinical Pathology
The American Society for Clinical Pathology Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pathology operates as a society of pathologists and laboratory professionals. The company was founded in 1922 and is headquartered in Chicago, IL. | Commercial Services |
Aravive Biologics, Inc.
Aravive Biologics, Inc. Pharmaceuticals: MajorHealth Technology Aravive Biologics, Inc. develops novel targeted therapeutics in oncology. The company was founded by Amato Giaccia and Albert Koong and is headquartered in Houston, TX. | Health Technology |
Meryx, Inc.
Meryx, Inc. Pharmaceuticals: MajorHealth Technology Meryx, Inc. operates as an immune-oncology company. It focuses on developing drugs that inhibit tumor growth and initiate anti-tumor immunity in a range of cancer, such as leukemia, lung cancer, and melanoma. The company was founded by Doug Graham, Shelley Earp, and Stephen Frye in 2007 and is headquartered in Chapel Hill, NC. | Health Technology |
Intellidev Consulting LLC |